EcoDrugPlus

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSGACG00000018894
Gene Symbol: AKR1B1.2
1 Cross references
348 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSGACG00000011709
Gene Symbol: GAA
1 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSGACG00000001050
Gene Symbol: AOC1
1 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSGACG00000005784
Gene Symbol: AOC2
1 Cross references
403 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSGACG00000003424
Gene Symbol: APPB
1 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSGACG00000015081
Gene Symbol: APP
2 Cross references
206 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSGACG00000020332
Gene Symbol: AR
4 Cross references
214 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSGACG00000003676
Gene Symbol: AGTR1
1 Cross references
203 Possible Orthologues:

Angiotensin Ii Receptor, Type 2

Ensembl ID : ENSGACG00000018540
Gene Symbol: AGTR2
1 Cross references
189 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSGACG00000003849
Gene Symbol: APLNR2
1 Cross references
172 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSGACG00000000735
Gene Symbol: ALOX12
1 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSGACG00000007762
Gene Symbol: ALOX5A
1 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).